VALIDOGEN GmbH is a leading Austrian contract research and development company in the field of microbial protein expression.
VALIDOGEN GmbH is a leading Austrian contract research and development company in the field of microbial protein expression.
Based on its technology platform known as UNLOCK PICHIA®, VALIDOGEN develops industrial protein production strains and bioprocesses for the manufacture of biopharmaceuticals, enzymes and various other recombinant proteins. Founded in 2008, the company has emerged to be a globally recognized player in the field of Pichia pastoris based protein expression. VALIDOGEN is a private company and subsidiary of the KonValue Group.
Join a highly skilled and experienced team with a strong background in molecular biology and bioprocessing.
Want to be part of VALIDOGEN?
As we are always on the lookout for qualified specialists, it is possible to submit an unsolicited application at any time.
We look forward to receiving your application (applications@validogen.com Contact person: Dr. Evelyn Trummer-Gödl)
For more information, please visit www.validogen.com, www.unlockpichia.com & sign up to our mailing list to keep up with latest developments and information around Pichia based protein expression.